Charles Sternberg, Associate Editor09.29.22
NANISX LLC, a spine medical device company that was recently formed by Dr. Kingsley R. Chin, has appointed former Medtronic and Nuvasive sales executive, David Flickinger MBA as its new chief executive officer (CEO).
Prior to a career in healthcare, Flickinger was an Infantry Officer in the United States Marine Corps, where he served as a platoon commander and company executive officer with 3d Battalion 1st Marine Division. Flickinger was also the co-founder of Doc Social, a physician education and social media platform launched in December of 2020.
“I couldn’t be more excited about the opportunity to build on the legacy and leadership of these KICVentures Group portfolio companies, NanoFuse Biologics, InSpan and Sacrix, now combined to be known as NANISX LLC. As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients. I’m looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential,” Flickinger remarked.
About David Flickinger
Flickinger has been in leadership positions at public companies such as Medtronic (MDT), Nuvasive (NUVA) and has held numerous sales leadership roles at Surgalign (SRGA) since its formation in 2020. He has proven experience in the spine and orthobiologics industry with influence on the buy and sell side of strategic mergers and acquisitions, management, development and deployment of strategic opportunities, the formation of distributor alliances and commercializing Coflex interspinous device and other innovative medical devices to the spine market.Prior to a career in healthcare, Flickinger was an Infantry Officer in the United States Marine Corps, where he served as a platoon commander and company executive officer with 3d Battalion 1st Marine Division. Flickinger was also the co-founder of Doc Social, a physician education and social media platform launched in December of 2020.
“I couldn’t be more excited about the opportunity to build on the legacy and leadership of these KICVentures Group portfolio companies, NanoFuse Biologics, InSpan and Sacrix, now combined to be known as NANISX LLC. As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients. I’m looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential,” Flickinger remarked.